GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.250
-0.060 (-2.60%)
At close: Jun 12, 2026, 4:00 PM EDT
2.230
-0.020 (-0.89%)
After-hours: Jun 12, 2026, 7:49 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.25 million as of June 12, 2026. Its market cap has increased by 1.11% in one year.
Market Cap
3.25M
Enterprise Value
-7.74M
1-Year Change
1.11%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.25M, a decrease of -87.14%. That is a compound annual growth rate of -48.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.25M | 30.16% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 4.03M |
| Revelation Biosciences | 3.89M |
| Virax Biolabs Group | 3.67M |
| 60 Degrees Pharmaceuticals | 3.62M |
| GeoVax Labs | 3.53M |
| Azitra | 3.43M |
| Clearmind Medicine | 3.40M |
| CDT Equity | 3.38M |